
More than half of Germany's medium-sized companies expect an economic downturn next year, according to a survey by the BVMW business association.
Christoph Ahlhaus, the association's chief executive, said on Saturday that "superficial reforms are no longer enough to get Germany back on track."
He said businesses expect the federal government to finally deliver on long-promised structural reforms and concrete relief measures in areas such as bureaucracy, the labour market, taxation and energy costs.
According to the survey, 54% of companies expect an economic slowdown, while only 22% anticipate an upswing. In addition, 42% of respondents said they plan to scale back investment in 2026, the association said.
Medium-sized companies, known as the Mittelstand, form the backbone of Germany's economy and account for a large share of employment and investment.
The German economy contracted in 2023 and 2024, while growth is forecast to be minimal this year and no meaningful recovery is expected in 2026.
The BVMW surveyed more than 1,000 Mittelstand companies in an online poll conducted between December 18 and 23.
LATEST POSTS
- 1
Flu season is ramping up, and some experts are "pretty worried" - 2
Investigate Business Mastercard Choices for Better Rewards and Rewards - 3
Rediscovering Imagination in Adulthood: Individual Creative Excursions - 4
Find the Lively Food Markets of South America - 5
Watch Blue Origin's huge New Glenn rocket ace its epic landing on a ship at sea (video)
Trump administration launches new immigration crackdowns in New Orleans and Minneapolis. Here are all the cities it has targeted so far.
How Much Has the Iran War Cost the Average American Per Day?
Daily Briefing: A bad flu season gets worse
Zelensky confidant dismissed from further posts amid bribery scandal
2 new malaria treatments announced as drug resistance grows
Lawsuit claims ChatGPT exacerbated man's delusions leading to murder-suicide
Robert Pattinson claims he's a pathological liar. What 'The Drama' star has said about his 'shtick'
7 Heavenly Espressos, One Do You Like?
US FDA declines to approve Corcept's drug for rare hormonal disorder












